scispace - formally typeset
M

Murray L. Barclay

Researcher at University of Otago

Publications -  194
Citations -  12695

Murray L. Barclay is an academic researcher from University of Otago. The author has contributed to research in topics: Inflammatory bowel disease & Population. The author has an hindex of 53, co-authored 190 publications receiving 11688 citations. Previous affiliations of Murray L. Barclay include University of Adelaide & Royal Adelaide Hospital.

Papers
More filters
Journal ArticleDOI

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

Andre Franke, +97 more
- 01 Dec 2010 - 
TL;DR: A meta-analysis of six Crohn's disease genome-wide association studies and a series of in silico analyses highlighted particular genes within these loci implicated functionally interesting candidate genes including SMAD3, ERAP2, IL10, IL2RA, TYK2, FUT2, DNMT3A, DENND1B, BACH2 and TAGAP.
Journal ArticleDOI

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

Carl A. Anderson, +113 more
- 01 Mar 2011 - 
TL;DR: A meta-analysis of six ulcerative colitis genome-wide association study datasets found many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1.
Journal ArticleDOI

A suggested approach to once-daily aminoglycoside dosing.

TL;DR: A method is proposed which uses a target area under the concentration-time curve (AUC) for the aminoglycoside based on the 24 h AUC that would result with conventional dosing, which is likely to be safer than existing guidelines.
Journal ArticleDOI

Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

TL;DR: Proton pump inhibitors have dramatically influenced the management of acid‐peptic disorders in recent years and are extensively metabolized in the liver via cytochromes P450 2C19 and 3A4.
Journal ArticleDOI

High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study

TL;DR: IBD is at least as common in Canterbury as in other western regions and CD incidence and prevalence are amongst the highest ever reported and are higher than for UC.